Executive Whistleblowers
  • In 2003, Bayer Corporation paid $257 million to settle civil and criminal charges that it defrauded Medicaid by overcharging for two popular drugs through a complex drug labeling scheme. The settlement arose from a qui tam suit in which Getnick & Getnick represented the relator, a director of corporate marketing at Bayer who had reported the scheme internally following a compliance lecture at Bayer, receiving no response.

  • A qui tam suit filed by a divisional reimbursement supervisor for the Columbia/HCA national hospital chain against his employer and an accounting firm that helped prepare Medicare cost reports resulted in a $9 million settlement with the accounting firm in 2001, and formed part of an $881 million settlement with the hospital chain in 2003.


  • In 2004, Gambro Healthcare, one of the nation's largest renal dialysis providers, paid a total of $350 in a civil settlement and criminal fines following a quit tam case filed by its Chief Medical Officer alleging that Gambro billed for unnecessary tests and services.


  • In 2001, TAP, a multinational pharmaceutical joint venture, agreed to pay $875 million to the federal government in the largest health care fraud settlement ever. The settlement arose from two qui tam cases, one filed by TAP's former Vice President of Sales, who alleged that the company gave kickbacks to doctors and encouraged them to defraud Medicare by billing for free samples of the drug Lupron. The other case was filed by the Medical Director of an HMO with which TAP did business, and who said he was offered a kickback by TAP salespeople to put Lupron on the HMO's formulary.


  • In 1998, the CFO of a Florida hospital in the Columbia/HCA chain turned in his employers after they responded inadequately to his reports that certain management fees submitted to Medicare for reimbursement were inflated. His qui tam case against the hospital chain and an affiliated would care company, Curative Health Services, recouped $16.5 million from Curative, and formed part of an $881 million settlement with the hospital chain in 2003.


  • A former Vice President of a home health care company filed a qui tam case in 1997 against his employer and a national hospital chain alleging that they made claims to Medicare for non-reimbursable marketing activities. In 1999 the home health company agreed to a $51 million settlement and $10 million in criminal fines. In 2000, the hospital chain settled this and a number of other qui tam cases for $745 million.


  • A qui tam lawsuit filed in 1993 by the former CFO of a Montana hospital against his employers alleging Medicare cost reporting fraud resulted in an $85 million settlement in 2001.


  • In 1989, a sales manager for one of the country's major clinical testing laboratories, National Health Labs, filed a qui tam case against his employers and other laboratories after they listened to his complaints alleging corrupt practices by a competitor -- and copied them. His lawsuit resulted in criminal charges, and civil recoveries totaling $149 million..


  • The National Health Laboratories settlement was followed by a number of additional qui tam cases against most of the nation's major clinical testing laboratories, ultimately recovering in excess of $1 billion. The single largest settlement in these cases -- $325 million -- arose from three qui tam cases, one filed by a senior billings system analyst for the laboratory, and another filed by a laboratory medical director.
Disclaimer
This Site supported by Getnick & Getnick Copyright © 2008

Designed, Developed and Maintained By Interactive Media Associates, Inc.